Moreover, glioma cells express increased levels of immunosuppressive factors such as PD-L1, TIGIT, CD96, and CTLA-4, which negatively regulate presentation of antigens and T-cell responses (46–48). The gene discussed is CD274; the disease is central nervous system cancer.